Our quarterly earnings per share was $4.10 well over the $3.82 of a year ago, which included a $0.2 charge for restructuring, and that's $4.10 was up 33.1% over 2019.
EPS $4.10 a considerable rise to new heights.
Net earnings of $223.7 million or $4.10 per diluted share increased $14.8 million, or $0.28 per share from last year's levels, representing a 7.3% increase in diluted earnings per share.
And it all came together for an earnings per share of $4.10, up 7.2% from last year and 33% from the pre-pandemic period, leading to a full-year earnings per share of $14.92, new heights despite the storm.
Organically, our sales grew by 2.3%.
Net sales of $1,108.3 million in the quarter increased 3.2% from 2020 levels, reflecting a 2.3% organic sales gain and $12.2 million of acquisition-related sales, partially offset by $3 million of unfavorable foreign currency translation.
We anticipate the capital expenditures will be in a range of $90 million to $100 million.
In addition, we currently anticipate absenting any changes to US tax legislation that our full-year 2022 effective income tax rate will be in the range of 23%, 24%.
